Shattuck Labs (STTK) Capital Expenditures (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Capital Expenditures of $63000.0 for Q1 2026, down 11.27% quarter-over-quarter from $71000.0 in Q3 2025.
Analysis
Shattuck Labs (STTK) Capital Expenditures (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Capital Expenditures for 8 consecutive years, with $63000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures changed N/A year-over-year to $63000.0; the TTM figure through Mar 2026 stood at $134000.0 (up 127.12% YoY), while the FY2025 annual figure was $71000.0, up 20.34% from the prior year.
- Capital Expenditures fell to $63000.0 in Q1 2026 per STTK's latest filing, from $71000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $10.7 million in Q3 2022 and bottomed at -$2.3 million in Q2 2022.
- Historically, Capital Expenditures has averaged $1.0 million across 5 years, with a median of $67000.0 in 2025.
- Annual changes were most pronounced in 2022 — Capital Expenditures tumbled 1576.92% — and 2024, when it jumped 121.05%.
- Shattuck Labs' Capital Expenditures stood at $693000.0 in 2022, then slumped by 97.55% to $17000.0 in 2023, then jumped by 147.06% to $42000.0 in 2024, then surged by 69.05% to $71000.0 in 2025, then retreated by 11.27% to $63000.0 in 2026.
- Business Quant data shows STTK's Capital Expenditures at $63000.0 in Q1 2026, $71000.0 in Q3 2025, and $42000.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 37.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 2.29 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 251.02 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Shattuck Labs | 885.09 Mn | 885.09 Mn | - | 78,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78,000.00 |
| Mar 31, 2026 | 63,000.00 |
| Sep 30, 2025 | 71,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 216,000.00 |
| Mar 31, 2023 | 155,000.00 |
| Dec 31, 2022 | 693,000.00 |
| Sep 30, 2022 | 750,000.00 |
| Jun 30, 2022 | 7.68 Mn |
| Mar 31, 2022 | 2.49 Mn |
| Dec 31, 2021 | 1.99 Mn |
| Sep 30, 2021 | 964,000.00 |
| Jun 30, 2021 | 2.33 Mn |
| Mar 31, 2021 | 2.64 Mn |
| Dec 31, 2020 | 201,000.00 |
| Sep 30, 2020 | 99,000.00 |
| Jun 30, 2020 | 319,000.00 |